Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Vera Therapeutics Inc (VERA)

225 + Investors. Track Smart Money conviction in VERA. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +11
Streak
2Q ▲
Buyers last Q
58%

Smart Money Signals — VERA

Based on 227 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added VERA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
227 hedge funds hold VERA right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +29% more funds vs a year ago

fund count last 6Q
+51 new funds entered over the past year (+29% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 58% buying

141 buying101 selling
Last quarter: 141 funds bought or added vs 101 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-22 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 37 → 32 → 67 → 45. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
📌

Mixed — 36% long-term, 30% new

■ 36% conviction (2yr+) ■ 34% medium ■ 30% new
Of the 227 current holders: 81 (36%) held >2 years, 78 held 1–2 years, and 68 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💎

Buying through price weakness — shares -2%, value -22%

Value
-21%
Shares
-2%
Last quarter: funds added -2% more shares while total portfolio value only changed -22%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
🚀

Acceleration phase — new buyers rushing in

32 → 37 → 32 → 67 → 45 new funds/Q
New funds entering each quarter: 37 → 32 → 67 → 45. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
📊

Mixed cohorts — 36% veterans, 36% new entrants

■ 36% veterans ■ 27% 1-2yr ■ 36% new
Of 237 current holders: 86 (36%) held 2+ years, 65 held 1–2 years, 86 (36%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
✅

Strong quality — 34% AUM from major funds

34% from top-100 AUM funds
48 of 226 holders rank in the top 100 by AUM, accounting for 34% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.3
out of 10
Moderate Exit Risk
Exit risk score 4.3/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — VERA

In 2026 Q1, 141 hedge funds were net buyers of VERA (45 opened a new position, 96 added to an existing one), while 101 reduced or exited (67 trimmed, 34 sold completely) — a 58% buyer ratio, indicating a slight buying edge. Net buying has persisted for two consecutive quarters, a positive momentum signal. 34% of total institutional value in VERA is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +11 funds (more new holders than closures). Total institutional holders: 227.

Hedge Fund Ownership: VERA

How many hedge funds hold VERA — quarterly history vs. share price
Quarterly hedge fund ownership of VERA vs. share price

Market Analysis: VERA

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: VERA

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Vera Therapeutics Inc (VERA) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much VERA has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 45d ago
VERA
-32.7%
XLV
+6.1%

VERA outperformed XLV by -38.8% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 0d ago
VERA
+0.0%
XLV
+0.0%

Since the filing became public, VERA outperformed XLV by +0.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

29 top-rated funds 7 high-conviction
Consensus
6.4
/ 10
breadth
×
Elite
4.6
/ 10
conviction
Hedge Fund Positioning: VERA
2026 Q2 Stats Unlock in 5 days 225 + Investors

Track Smart Money conviction in VERA. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 225 216 4.17%
13F Shares 73M 75M -2.56%
Total Value $2.76B $3.53B -21.84%
New Positions 43 67 -24
Increased Positions 94 78 +16
Closed Positions 34 22 +12
Reduced Positions 65 59 +6
Total Calls 7 7 -
Total Puts 4 4 -
PUT/CALL Ratio 0.57 0.57 Bullish

Statistics: VERA

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

225 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in VERA. Verified SEC 13F-HR filings.

QUARTER:
2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 VERA holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Davern Capital Partners, LP 3.65% 498,832 $21.4M
2 Integral Health Asset Management, LLC 2.97% 1,750,000 $75.1M
3 Deep Track Capital, LP 2.50% 4,000,000 $171.6M
4 Avoro Capital Advisors LLC 2.21% 5,723,888 $245.6M
5 Platinum Investment Management Ltd 1.20% 113,687 $4.9M
6 HighVista Strategies LLC 1.04% 105,907 $4.5M
7 KVP Capital Advisors, LP 1.03% 32,700 $1.4M
8 Sectoral Asset Management Inc 0.77% 25,573 $1.1M
9 Knott David M Jr 0.59% 26,000 $1.1M
10 Frontier Capital Management Co LLC 0.52% 1,295,405 $55.6M
11 Affinity Asset Advisors, LLC 0.48% 250,000 $10.7M
12 CenterBook Partners LP 0.38% 179,467 $7.7M
13 Persistent Asset Partners Ltd 0.21% 16,485 $707K
14 PSP Research LLC 0.16% 7,000 $300K
15 Bayforest Capital Ltd 0.11% 2,854 $122K
16 Ghisallo Capital Management LLC 0.11% 125,000 $5.4M
17 Virtus Investment Advisers, LLC 0.10% 9,550 $410K
18 Candriam S.C.A. 0.09% 468,099 $20.1M
19 E. Ohman J:or Asset Management AB 0.09% 85,777 $3.7M
20 Ami Asset Management Corp 0.08% 30,582 $1.3M
21 Hennion & Walsh Asset Management, Inc. 0.05% 42,506 $1.8M
22 Pictet Asset Management Holding SA 0.05% 1,249,414 $53.6M
23 Algert Global LLC 0.05% 92,250 $4.0M
24 Profund Advisors LLC 0.04% 37,062 $1.6M
25 NINE MASTS CAPITAL Ltd 0.04% 9,434 $405K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Vera Therapeutics Inc (VERA)

What does the Smart Money Trend signal show for VERA?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added VERA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for VERA?

Slight buying edge — 58% buying: Last quarter: 141 funds bought or added vs 101 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for VERA holders?

Strong quality — 34% AUM from major funds: 48 of 226 holders rank in the top 100 by AUM, accounting for 34% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held VERA?

Mixed — 36% long-term, 30% new: Of the 227 current holders: 81 (36%) held >2 years, 78 held 1–2 years, and 68 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Vera Therapeutics Inc (VERA) following the 2026 Q2 hedge fund 13F filings?

As of today, VERA has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), VERA has gained -32.7% vs +6.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →